Zeo ScientifiX, Inc.
ZEOXOTCHealthcare · Biological Products, (No Diagnostic Substances) · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $5.2M | $4.6M | $4.6M | $6.5M | $5.6M | $95,455 |
| Operating income | −$5.4M | −$5.3M | −$6.8M | −$8.8M | −$12.7M | −$12.4M |
| Net income | −$5.5M | −$4.7M | −$7.0M | −$8.9M | −$12.8M | −$12.6M |
| Total assets | $1.5M | $1.6M | $2.8M | $6.2M | $1.9M | $1.3M |
| Total liabilities | $3.0M | $3.3M | $4.0M | $4.3M | $4.6M | $2.7M |
| Equity | −$1.4M | −$1.7M | −$1.2M | $1.9M | −$2.7M | −$1.4M |
| EPS (diluted) | $-0.86 | $-0.74 | $-0.99 | $-1.56 | — | — |
| Shares out. | 6.3M | 6.1M | 1.46B | 1.15B | 992.2M | 875.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −103.6%
- Net margin
- −106.2%
- Return on equity
- 388.0%
- Return on assets
- −361.6%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 193.2%
- Debt / equity
- —
- Book value / share
- $-0.22
- Revenue growth (YoY)
- 12.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -177.04distress
- Accruals / assets
- −314.5%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Jun 14, 2023
- NT 10-Kmissed a reporting deadline ↗Jan 30, 2023
- NT 10-Kmissed a reporting deadline ↗Jan 31, 2022
- NT 10-Kmissed a reporting deadline ↗Jan 29, 2021
- NT 10-Qmissed a reporting deadline ↗Jun 15, 2018
- NT 10-Kmissed a reporting deadline ↗Jan 29, 2018
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Bothwell Ian TActivist (13D)May 15, 2026
- Greyt Ventures, LlcActivist (13D)Feb 6, 2026
- Skycrest Holdings, LlcActivist (13D)Oct 20, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 9,569 | 1.0 | +239125.0% |
| Apr 30, 2026 | 4 | 1.0 | +100.0% |
| Mar 31, 2026 | 10,043 | 1.1 | +33.8% |
| Mar 13, 2026 | 7,508 | 1.0 | +6.4% |
| Feb 27, 2026 | 7,058 | 1.1 | +1034.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 27, 2026
- Other material eventMay 12, 2026
- Other material eventApr 21, 2026
- Other material eventApr 9, 2026
- Other material eventApr 7, 2026
- Other material eventMar 31, 2026
- Director / officer changeMar 27, 2026
- Director / officer changeJan 28, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.